Feingold K R, Wiley M H, Moser A H, Lear S R
Diabetes. 1983 Apr;32(4):368-76. doi: 10.2337/diab.32.4.368.
Previous studies have demonstrated that de novo cholesterol synthesis is increased two- to threefold in the intestines of diabetic animals. This increase is due to a stimulation of cholesterogenesis in both the small and large intestine but, quantitatively, the small intestine is primarily responsible for the observed increase. The present study examined the effect of cholesterol feeding and alterations of bile acid homeostasis on de novo sterol synthesis in intact normal and diabetic animals. Cholesterol feeding in the control animals did not affect sterol synthesis in the small intestine, but in diabetic animals cholesterol feeding markedly inhibited small intestinal sterologenesis. The threefold stimulation of small intestinal sterol synthesis observed in diabetic animals is completely obliterated by cholesterol ingestion. Moreover, this inhibition of sterol synthesis by cholesterol feeding in the small intestine of diabetic animals occurred very rapidly (within 36 h). In the large intestine, cholesterol feeding did not influence sterol synthesis in either the diabetic or control animals. In the liver, cholesterol feeding markedly inhibited sterol synthesis to similar degrees in the diabetics and controls. Colestipol feeding and biliary drainage, procedures that reduce bile acid pool size, stimulated sterol synthesis in the liver and small intestine of both diabetic and control animals. However, reductions in bile acid pool size increased sterologenesis in the large intestine in control animals but had no effect in the diabetics. Bile acid ingestion did not alter either small or large intestinal sterologenesis in the diabetic or control animals. In conclusion, the present study demonstrates the sterol synthesis is enhanced in the small and large intestine of diabetic animals and, moreover, both the cholesterol- and bile acid-mediated regulation of cholesterol synthesis in the intestines of the diabetic animals is altered from normal.
先前的研究表明,糖尿病动物肠道中的从头胆固醇合成增加了两到三倍。这种增加是由于小肠和大肠中胆固醇生成均受到刺激,但从数量上看,小肠是观察到的增加的主要原因。本研究检测了喂食胆固醇以及改变胆汁酸稳态对完整正常和糖尿病动物从头固醇合成的影响。在对照动物中喂食胆固醇不影响小肠中的固醇合成,但在糖尿病动物中,喂食胆固醇显著抑制小肠固醇生成。糖尿病动物中观察到的小肠固醇合成的三倍刺激被胆固醇摄入完全消除。此外,在糖尿病动物小肠中,喂食胆固醇对固醇合成的这种抑制作用非常迅速(在36小时内)。在大肠中,喂食胆固醇对糖尿病动物和对照动物的固醇合成均无影响。在肝脏中,喂食胆固醇在糖尿病动物和对照动物中均显著抑制固醇合成,且抑制程度相似。服用考来烯胺和进行胆汁引流这两种减小胆汁酸池大小的操作,刺激了糖尿病动物和对照动物肝脏及小肠中的固醇合成。然而,减小胆汁酸池大小会增加对照动物大肠中的固醇生成,但对糖尿病动物没有影响。摄入胆汁酸对糖尿病动物和对照动物的小肠或大肠固醇生成均无改变。总之,本研究表明糖尿病动物的小肠和大肠中固醇合成增强,而且,糖尿病动物肠道中胆固醇和胆汁酸介导的胆固醇合成调节与正常情况相比发生了改变。